NPI registry status
Active
2026 NPPES data Allergy & Immunology Physician NPI 1467682799 M.D.
Verify on CMS → Vivek Agarwal, M.D.
Allergy & Immunology Physician in Silverdale, Washington.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,412 in Allergy & Immunology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
837
Medicare Part D claims · 165 beneficiaries · Allergy & Immunology Physician avg: 788
Generic prescribing
56%
generic claims · 44% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$2.1K
87 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Vivek Agarwal, M.D. filed 837 Medicare Part D claims in 2024 as an Allergy & Immunology Physician in Silverdale, Washington, prescribing 56% generic.
- 837
- Part D claims, 2024
- 56%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥72nd
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Vivek Agarwal, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1467682799), first enumerated 07/21/2009.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 837 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$2.1K in reported industry payments (87 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Washington statewide board action statistics are published annually — these figures describe aggregate state activity, not Vivek Agarwal, M.D.'s individual license status. Verify directly with the state medical board.
Source: WMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1467682799 · Allergy & Immunology Physician
NPI-10 · ENUM-MID · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1467682799
- ENUM-MID 2009
- TAX-NARROW 3,412
- RX-LIGHT 837
- BOOK-THIN 77 in Washington
- PHOTO-ENUM Stephanie Leeds, M.D. · 2009
Vivek Agarwal, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
837 ≥ 72nd percentile 72% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Vivek Agarwal, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Vivek Agarwal, M.D.?
Quality data not reportedPrimary specialty
Allergy & Immunology Physician
Medicare Part D claims
837 6% vs specialty avg
Specialty distribution in Washington
How Allergy & Immunology Physician compares to other specialties among Washington providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Allergy & Immunology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1467682799 |
|---|---|
| Specialty | Allergy & Immunology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/21/2009 |
Hospital and facility affiliations
Facilities where Vivek Agarwal, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Franciscan Medical Group
Silverdale, WA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Vivek Agarwal, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$2.1K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Washington WMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 - they are NOT specific to Vivek Agarwal, M.D.. To verify Vivek Agarwal, M.D.'s current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases
WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Vivek Agarwal, M.D. - brand share 44.0%
Allergy & Immunology Physician average
44% brand-name claims vs 56% generic, on 837 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
837
Total Claims
$913K
Total Drug Cost
165
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,066.133
- Total Day Supply
- 28,534
- Brand vs Generic
- 44% brand / 56% generic
- Brand Drug Cost
- $895K
- Generic Drug Cost
- $18K
- Antibiotic Claims
- 20
Patient Demographics
- Average Patient Age
- 69.9 years
- Avg HCC Risk Score
- 1.01
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 24, 65-74: 88, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Vivek Agarwal, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Montelukast Sodium
Montelukast Sodium
109 claims
- Ipratropium Bromide
Ipratropium Bromide
95 claims
- Dupixent Pen
Dupixent Pen
78 claims
- Xolair
Xolair
71 claims
- Epinephrine
Epinephrine
49 claims
- Azelastine Hcl 41
Azelastine Hcl
41 claims
- Trelegy Ellipta 38
Trelegy Ellipta
38 claims
- Fluticasone Propio… 33
Fluticasone Propionate
33 claims
| Drug | Claims |
|---|---|
| Montelukast Sodium | 109 |
| Ipratropium Bromide | 95 |
| Dupixent Pen Dupilumab | 78 |
| Xolair Omalizumab | 71 |
| Epinephrine | 49 |
| Azelastine Hcl | 41 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 38 |
| Fluticasone Propionate | 33 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 32 |
| Prednisone | 26 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Allergy & Immunology Physician Overview
How Vivek Agarwal, M.D. fits within the Allergy & Immunology Physician landscape nationally.
3,412
Allergy & Immunology Physician Providers in US
52
States with Allergy & Immunology Physician
788
Avg Claims per Provider
Vivek Agarwal, M.D.'s 837 claims are above the specialty average of 788.
Nationwide Allergy & Immunology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Agarwal, both outside Washington so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2009)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Allergy & Immunology Physician Providers in Washington
Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as Agarwal.
One of 77 Allergy & Immunology Physician providers enrolled in Washington, 5 are shown here.
Dr. George Allen
MD
Vancouver, WA
Dr. Leonard Altman
M.D.
Seattle, WA
Dr. William Anderson
M.D.
Bellingham, WA
Dr. W Andrade
MD
Lakewood, WA
Dr. Nola Attaway
M.D.
Yakima, WA
Compare Allergy & Immunology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Vivek Agarwal, M.D.'s specialty? ▼
Vivek Agarwal, M.D. specializes in Allergy & Immunology Physician and practices in Silverdale, Washington. Credentials: M.D..
How much does Vivek Agarwal, M.D. prescribe under Medicare Part D? ▼
In 2024, Vivek Agarwal, M.D. wrote 837 Medicare Part D claims totaling $913K in drug costs for 165 beneficiaries.
Where is Vivek Agarwal, M.D. located? ▼
Vivek Agarwal, M.D. is located at 2011 NW MYHRE PL, Silverdale, WA, 98383. Phone: (360) 830-1706.
What is Vivek Agarwal, M.D.'s NPI number? ▼
Vivek Agarwal, M.D.'s National Provider Identifier (NPI) is 1467682799, issued on 07/21/2009.
Does Vivek Agarwal, M.D. prescribe more brand-name or generic drugs? ▼
Vivek Agarwal, M.D.'s prescribing is 44% brand-name and 56% generic drugs by claim count, with $895K in brand drug costs.
How many Allergy & Immunology Physician providers are there in the US? ▼
There are 3,412 Allergy & Immunology Physician providers across 52 states in the US. The average Allergy & Immunology Physician provider writes 788 Medicare Part D claims per year.
What drugs does Vivek Agarwal, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Vivek Agarwal, M.D.'s most frequently prescribed drugs include Montelukast Sodium, Ipratropium Bromide, Dupixent Pen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Vivek Agarwal, M.D. accept Medicare? ▼
Vivek Agarwal, M.D. appears in CMS Medicare data with 837 Part D claims and 165 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Vivek Agarwal, M.D.'s credentials? ▼
Vivek Agarwal, M.D.'s NPI is 1467682799 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.